<DOC>
	<DOCNO>NCT01937559</DOCNO>
	<brief_summary>The objective study evaluate efficacy topical tranexamic acid ( TXA ) decrease blood loss follow shoulder arthroplasty primary total hip arthroplasty . TXA function decrease blood loss affect blood clotting system within body . The investigator hypothesize topical application TXA prior closure reduces postoperative bleeding measure absolute change postoperative hemoglobin level surgical drain output . In addition , use topically apply tranexaminic acid may reduce need transfusion , rate hematomas , infection , length hospital stay .</brief_summary>
	<brief_title>Topical Tranexamic Acid ( TXA ) Joint Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Shoulders : All adult patient age 18 schedule primary total arthroplasty primary reverse shoulder arthroplasty eligible inclusion study . Hips : All adult patient age 18 schedule primary total hip arthroplasty eligible inclusion study . allergy TXA , refusal blood product , preoperative use anticoagulant therapy within 5 day surgery , history seizure , renal failure ( creatine clearance &lt; 30ml/min ) , bleed disorder , venous thromboembolism ( deep vein thrombosis and/or pulmonary embolism ) , significant cardiac history ( myocardial infarction , angina , stroke , low limb ischemia ) , perioperative anemia ( hemoglobin &lt; 11g/dl female &lt; 12g/dl male ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>tranexaminic acid ( TXA )</keyword>
</DOC>